HeartSciences Inc.
NASDAQ: HSCSW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Andrew Simpson
- Employees
- 15
- Headquarters
- Southlake, United States
- IPO year
- 2022
- Market cap
- $164.7K
- Website
- https://heartsciences.com
Loading HSCSW…
Loading profile data…Frequently asked questions about HSCSW
What does HeartSciences Inc. (HSCSW) do?
Heart Test Laboratories, Inc. is a medical technology enterprise dedicated to the creation of diagnostic instruments for cardiovascular health. The company's primary offering is the MyoVista wavECG, a sophisticated 12-lead resting electrocardiograph. This device provides essential diagnostic insights into cardiac dysfunction, in addition to supp...
Where does HSCSW trade?
HeartSciences Inc. (HSCSW) trades on the NASDAQ Capital Market.
What sector is HSCSW in?
HeartSciences Inc. (HSCSW) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of HeartSciences Inc.?
Andrew Simpson is the chief executive officer of HeartSciences Inc. (HSCSW).
Where is HeartSciences Inc. headquartered?
HeartSciences Inc. is headquartered in United States.
Does HSCSW pay a dividend?
HeartSciences Inc. (HSCSW) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HSCSW go public?
HeartSciences Inc. (HSCSW) completed its initial public offering in 2022.